Nurix Therapeutics, Inc. Quarterly Current Ratio in % from Q2 2021 to Q1 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Nurix Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q2 2021 to Q1 2025.
  • Nurix Therapeutics, Inc. Current Ratio for the quarter ending February 28, 2025 was 592 %, a 65.3% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.